申请人:Eli Lilly and Company
公开号:US05814646A1
公开(公告)日:1998-09-29
A method of protecting a warm-blooded mammal from the progression of Alzheimer's disease, which comprises administering an effective amount of a compound of general formula. ##STR1## in which: R.sup.1 represents an optionally substituted aromatic or heteroaromatic group; L.sup.1 and L.sup.2 each independently represents a bond or an unbranched (1-4C) alkylene group, which alkylene group may optionally bear a (1-4C) alkyl, phenyl or phenyl (1-2C) alkyl substituent; one of Y.sup.1 and Y.sup.2 represents NR.sup.3 and the other represents O, S or NR.sup.3, in which R.sup.3 represent hydrogen, hydroxyl, (1-4C) alkoxy, (1-4C) alkyl or di (1-4C) alkylamino; Z represents O or S; and R.sup.2 represents (3-8C) cycloalkyl, heterocyclyl, and optionally substituted aromatic or heteroaromatic group, or together with L.sup.2, (1-10C) alkyl; or a pharmaceutically acceptable salt thereof.
一种保护温血哺乳动物免受阿尔茨海默病进展的方法,包括给予一定量的一般式化合物。##STR1##其中:R.sup.1代表可选择取代的芳香族或杂芳族基团;L.sup.1和L.sup.2各自独立代表键或直链(1-4C)烷基基团,该烷基基团可能可选择携带(1-4C)烷基、苯基或苯基(1-2C)烷基取代基;Y.sup.1和Y.sup.2中的一个代表NR.sup.3,另一个代表O、S或NR.sup.3,其中R.sup.3代表氢、羟基、(1-4C)烷氧基、(1-4C)烷基或二(1-4C)烷基氨基;Z代表O或S;R.sup.2代表(3-8C)环烷基、杂环烷基和可选择取代的芳香族或杂芳族基团,或与L.sup.2一起,(1-10C)烷基;或其药学上可接受的盐。